Recent advances in design and synthesis of self-adjuvanting lipopeptide vaccines

International Journal of Peptide Research and Therapeutics

Volumn 14, Issue 4, 2008, Pages 333-340

  Toth, Istvan ^a   Simerska, Pavla ^a   Fujita, Yoshio ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adjuvant; Carbohydrate; Lipid; Peptide; Vaccine

Indexed keywords

4' MONOPHOSPHORYL LIPID A; ANTIBODY; ANTIGEN; CARBOHYDRATE DERIVATIVE; DNA VACCINE; EPITOPE; FREUND ADJUVANT; GLYCOLIPID; GLYCOPEPTIDE; LIPID; LIPID A DERIVATIVE; LIPOPEPTIDE; MANNOSE RECEPTOR; PEPTIDE VACCINE; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; B LYMPHOCYTE; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; DRUG TARGETING; GEOMETRY; HELPER CELL; HUMAN; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEPTIDE SYNTHESIS; POLYMERIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; UTERINE CERVIX CANCER;

EID: 57349098637     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-008-9147-y     Document Type: Conference Paper

References (73)

1. ABM Abdel-Aal MR Batzloff Y Fujita N Barozzi A Faria P Simerska PM Moyle MF Good I Toth 2008 Structure-activity relationships of a series of synthetic lipopeptide self-adjuvanting group A streptococcal vaccine candidates J Med Chem 51 1 167 172
2. R Arnon 1991 Synthetic peptides as the basis for vaccine design Mol Immunol 28 3 209 215
3. JR Baldridge P McGowan JT Evans C Cluff S Mossman D Johnson D Persing 2004 Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents Expert Opin Biol Ther 4 7 1129 1138
4. MR Baldwin WH Tepp A Przedpelski CL Pier M Bradshaw EA Johnson JT Barbieri 2008 Subunit vaccine against the seven serotypes of botulism Infect Immun 76 3 1314 1318
5. JP Behr 1994 Gene-transfer with synthetic cationic amphiphiles-prospects for gene-therapy Bioconjug Chem 5 5 382 389
6. WH Binder C Kluger 2006 Azide/alkyne-"click" reactions: Applications in material science and organic synthesis Curr Org Chem 10 1791 1815
7. JT Blanchfield RA Lew IA Smith I Toth 2005 The stability of lipidic analogues of GnRH in plasma and kidney preparations: the stereoselective release of the parent peptide Bioorg Med Chem Lett 15 6 1609 1612
8. I Bourgault F Chirat A Tartar JP Lévy JG Guillet A Venet 1994 Simian immunodeficiency virus as a model for vaccination against HIV-induction in Rhesus macaques of GAS-specific or NEF-specific cytotoxic T-lymphocytes by lipopeptides J Immunol 152 5 2530 2537
9. ER Brandt KS Sriprakash RI Hobb WA Hayaman W Zeng MR Batzloff DC Jackson MF Good 2000 New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population Nat Med 6 4 455 459
10. PE Dawson TQ Muir I Clark-Lewis SBH Kent 1994 Synthesis of proteins by native chemical ligation Science 266 776 779
11. K Deres H Schild KH Wiesmüller G Jung HG Rammensee 1989 In vivo priming of virus-specific cyto-toxic lymphocytes-T with synthetic lipopeptide vaccine Nature 342 6249 561 564
12. C Durier O Launay V Meiffrédy Y Saïda D Salmon Y Lévy JG Guillet G Pialoux J-P Aboulker 2006 Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults AIDS 20 7 1039 1049
13. GM Dykes DK Smith 2003 Supramolecular dendrimer chemistry: using dendritic crown ethers to reversibly generate functional assemblies Tetrahedron 59 3999 4009
14. AJ Engering M Cella D Fluitsma M Brockhaus EC Hoefsmit A Lanzavecchia J Pieters 1997 The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells Eur J Immunol 27 9 2417 2425
15. TM adjuvant and Ribi.529 Expert Rev Vaccines 2 2 219 229
16. N Flinn I Hussain A Shaw P Artursson WA Gibbons I Toth 1996 Oral absorption studies of lipid-polylysine conjugates of thyrotropin releasing hormone (TRH) and luteinizing hormone releasing hormone (LHRH) Int J Pharm 138 2 167 174
17. H Frey C Schlenk 2000 Silicon-based dendrimers Top Curr Chem 210 69 129
18. Fujita Y, Abdel-Aal ABM, Wimmer N, Batzloff MR, Good MF, Toth I (2008) Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates. Bioorg Med Chem. doi: 10.1016/j.bmc.2008.08064
19. S Ghosh DC Jackson 1999 Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines Int Immunol 11 7 1103 1110
20. WA Gibbons RA Hughes A Szeto M Charalambous A Aulabaugh P Mascagni I Toth 1990 Lipidic peptides 1. Synthesis, resolution and structural elucidation of lipidic amino-acids and their homo-oligomers and heterooligomers Liebigs Ann Chem 12 1175 1183
21. M Golovkin S Spitsin V Andrianov Y Smirnov Y Xiao N Pogrebnyak K Markley R Brodzik Y Gleba SN Isaacs H Koprowsk 2007 Smallpox subunit vaccine produced in planta confers protection in mice Proc Natl Acad Sci USA 104 16 6864 6869
22. RK Gupta RG Siber 1995 Adjuvants for human vaccines-current status, problems and future prospects Vaccine 13 14 1263 1276
23. RK Gupta EH Relyveld EB Lindblad B Bizzini S Ben-Efraim CK Gupta 1993 Adjuvants-a balance between toxicity and adjuvanticity Vaccine 11 3 293 306
24. B Guy 2007 The perfect mix: recent progress in adjuvant research Nat Rev Microbiol 5 7 505 517
25. TM Hackeng JH Griffin PE Dawson 1999 Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology Proc Natl Acad Sci USA 96 18 10068 10073
26. K Hantke V Braun 1973 Covalent binding of lipid to protein-diglyceride and amide-linked fatty-acid at N-terminal end of murein-lipoprotein of Escherichia coli outer membrane Eur J Biochem 34 2 284 296
27. W Hayman I Toth N Flinn M Scanlon M Good 2002 Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology Immunol Cell Biol 80 2 178 187
28. LA Herzenberg T Tokuhisa LA Herzenberg 1980 Carrier-priming leads to hapten-specific suppression Nature 285 5767 664 667
29. TP Hopp 1984 Immunogenicity of a synthetic HBSAG peptide-enhancement by conjugation to a fatty-acid carrier Mol Immunol 21 1 13 16
30. A Horváth C Olive A Wong T Clair P Yarwood M Good I Toth 2002 Lipoamino acid-based adjuvant carrier system: Enhanced immunogenicity of group a streptococcal peptide epitopes J Med Chem 45 6 1387 1390
31. A Horváth C Olive L Karpati HK Sun M Good I Toth 2004 Toward the development of a synthetic group A streptococcal vaccine of high purity and broad protective coverage J Med Chem 47 16 4100 4101
32. W Huang B Nardelli JP Tam 1994 Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine Mol Immunol 31 15 1191 1199
33. KJ Jensen G Barany 2000 Carbopeptides: carbohydrates as potential templates for de novo design of protein models J Pept Res 56 1 3 11
34. KD Johnstone M Dieckelmann MP Jennings I Toth JT Blanchfield 2005 Chemo-enzymatic synthesis of a trisaccharide-linked peptide aimed at improved drug-delivery Curr Drug Deliv 2 215 222
35. T Keler V Ramakrishna MW Fanger 2004 Mannose receptor-targeted vaccines Expert Opin Biol Ther 4 12 1953 1962
36. B Kellam B Drouillat G Dekany MS Starr I Toth 1998 Synthesis and in vitro evaluation of lipoamino acid and carbohydrate-modified enkephalins as potential antinociceptive agents Int J Pharm 161 1 55 64
37. M Kwissa SP Kasturi B Pulendran 2007 The science of adjuvants Expert Rev Vaccines 6 5 673 684
38. FD Ledley 1996 Pharmaceutical approach to somatic gene therapy Pharm Res 13 11 1596 1614
39. W Linder FA Robey 1987 Automated synthesis and use of N-chloroacetyl-modified peptides for the preparation of synthetic peptide polymers and peptide-protein immunogens Int J Pept Protein Res 30 794 800
40. YA Lu P Clavijo M Galantino ZY Shen W Liu JP Tam 1991 Chemically unambiguous peptide immunogen-preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system Mol Immunol 28 6 623 630
41. RI Mahato A Rolland E Tomlinson 1997 Cationic lipid-based gene delivery systems: Pharmaceutical perspectives Pharm Res 14 7 853 859
42. PM Moyle C Olive MF Ho MF Good I Toth 2006 Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A Streptococcal vaccine, and subsequent immunological evaluation J Med Chem 49 21 6364 6370
43. PM Moyle C Olive MF Good I Toth 2006 Method for the synthesis of highly pure vaccines using the lipid core peptide system J Pept Sci 12 12 800 807
44. PM Moyle C Olive MF Ho M Pandey J Dyer A Suhrbier Y Fujita I Toth 2007 Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines J Med Chem 50 19 4721 4727
45. PM Moyle Y Hari N Huamg C Olive MF Good I Toth 2007 A technique for the synthesis of highly-pure, mono-epitopic, multi-valent lipid core peptide vaccines Tetrahedron Lett 48 29 4965 4967
46. RF Muhlradt M Kiess H Meyer R Sussmuth G Jung 1997 Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at pico molar concentration J Exp Med 185 11 1951 1958
47. P Niederhafner J Šebestìk J Ježek 2005 Peptide dendrimers J Pept Sci 11 12 757 788
48. P Niederhafner J Šebestìk J Ježek 2008 Glycopeptide dendrimers. Part II J Pept Sci 14 14 44 65
49. C Olive HK Sun MF Ho J Dyer A Horvath I Toth MF Good 2006 Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein J Infect Dis 194 316 324
50. A Pashine NM Valiante JB Ulmer 2005 Targeting the innate immune response with improved vaccine adjuvants Nat Med 11 4 S63 S68
51. E Peduzzi N Westerfeld R Zurbriggen G Pluschke CA Daubenberger 2008 Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial Clin Immun 127 2 188 197
52. CRH Raetz C Whitefoeld 2002 Lipopolysaccharide endotoxins Annu Rev Biochem 71 635 700
53. FA Robey RL Fields 1989 Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide protein conjugates, and cyclic-peptides Anal Biochem 177 373 377
54. K Rose W Zeng LE Brown DC Jackson 1995 A synthetic peptide-based polyoxime vaccine construct of high purity and activity Mol Immunol 32 14/15 1031 1037
55. BP Ross I Toth 2005 Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers Curr Drug Deliv 2 3 277 287
56. MP Schutze C Leclerc M Jolivet F Audibert L Chedid 1985 Carrier-induced epitopic suppression, a major issue for future synthetic vaccines J Immunol 135 4 2319 2322
57. P Simerska AM Abdel-Aal Y Fujita RP McGeary PM Moyle MR Batzloff C Olive M Good I Toth 2008 Development of a liposaccharide-based delivery system and its application to the design of group streptococcal vaccines J Med Chem 51 5 1447 1452
58. SP Singh S Agrawal BN Mishra 2006 Malaria vaccine development: an application of bioinformatics and immunoinformatics tools to derive genome-wide subunit vaccine candidates Bioinformatics Trends 1 1 59 68
59. PJ Tacken R Torensma CG Figdor 2006 Targeting antigens to dendritic cells in vivo Immunobiology 211 6-8 599 608
60. JP Tam 1988 Synthetic peptide vaccine design-synthesis and properties of a high-density multiple antigenic peptide system Proc Natl Acad Sci USA 85 15 5409 5413
61. JP Tam P Clavijo YA Lu V Nussenzweig R Nussenzweig F Zavala 1990 Incorporation of T-epitopes and B-epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria J Exp Med 171 1 299 306
62. MC Tan AM Mommaas JW Drijfhout R Jordens JJ Onderwater D Verwoerd AA Mulder AN van der Heiden D Scheidegger LC Oomen TH Ottenhoff A Tulp JJ Neefjes F Koning 1997 Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells Eur J Immunol 27 9 2426 2436
63. S Thoelen P Van Damme C Mathei G Leroux-Roels I Desombere A Safary P Vandepapeliere M Slaoui A Meheus 1998 Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system Vaccine 16 7 708 714
64. J Torresi OM Stock AE Fischer L Grollo H Drummer I Boo W Zeng L Earnest-Silveira DC Jackson 2007 A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus Hepatology 45 4 911 920
65. I Toth JP Malkinson NS Flinn B Drouillat A Horvath J Erchegyi M Idei A Venetianer P Artursson L Lazorova B Szende G Keri 1999 Novel lipoamino acid- and liposaccharide-based system for peptide delivery: application for oral administration of tumor-selective somatostatin analogues J Med Chem 42 19 4010 4013
66. A Vitiello G Ishioka HM Grey R Rose P Famess R LaFound L Yuan FV Chisari J Fueze R Bartholomeuz RW Chesnut 1995 Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. 1. Induction of a primary cytotoxic T-lymphocyte response in humans J Clin Invest 95 1 341 349
67. LX Wang J Ni S Singh 2003 Carbohydrate-centered maleimide cluster as a new type of templates for multivalent peptide assembling: synthesis of multivalent HIV-1 gp41 peptides Bioorg Med Chem 11 1 159 166
68. CJ Wheeler PL Felgner YJ Tsai J Marshall L Sukhu SG Doh J Hartikka J Nietupski M Manthorpe M Nichols M Plewe X Liang J Norman A Smith SH Cheng 1996 A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung Proc Natl Acad Sci USA 93 1 11454 11459
69. J Zabner AJ Fasbender T Moninger KA Poellinger MJ Welsh 1995 Cellular and molecular barriers to gene-transfer by a cationic lipid J Biol Chem 270 32 18997 19007
70. W Zeng DC Jackson K Rose 1996 Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry J Pept Sci 2 1 66 72
71. W Zeng DC Jackson J Murray K Rose LE Brown 2000 Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens Vaccine 18 11-12 1031 1039
72. W Zeng S Ghosh M Macris J Pagnon DC Jackson 2001 Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: influence of different chemical linkages and epitope orientations on biological activity Vaccine 19 28-29 3843 3852
73. L Zhang JP Tam 1996 Thiazolidine formation as a general and site-specific conjugation method for synthetic peptides and proteins Anal Biochem 233 1 87 93